Contact Us

MEETING NEWS

Kexing Biopharm Obtained IND Approval for Its Self-developed GB05 from U.S. FDA

Feb 17, 2025

SHENZHEN,China,Feb. 14,2025-- Kexing Biopharm Co.,Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05,Human Interferon α1b Inhalation Solution,

Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases

Feb 17, 2025

BOSTON,Feb. 14,2025-- Bambusa Therapeutics,Inc. (Bambusa),a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders,today announced the successfu

A Global Leader! Huawei Cloud Stack Ranks No. 1 in Strategy and Execution of CloudOps Worldwide

Feb 17, 2025

SHENZHEN,China,Feb. 14,2025-- Omdia released the Omdia Universe: CloudOps,2025 report recently. In the report,Huawei was ranked No. 1 globally in CloudOps in terms of strategy and execution,and No. 2

CRIMSONLOGIC AND BDO SINGAPORE SIGN STRATEGIC PARTNERSHIP TO DEVELOP SPECIALIZED GENERATIVE AI ADVISORY PLATFORM

Feb 14, 2025

This strategic partnership aims to transform professional advisory services by leveraging cutting-edge Generative AI to provide accurate,domain-specific insights

Webull Masters 2025 Kicks Off: an Exciting Stock Trading Competition in Thailand with Over THB170,000 in Prizes

Feb 14, 2025

BANGKOK,Feb. 13,2025-- Webull Securities (Thailand) Co. Ltd. ("Webull Thailand"),the Thai subsidiary of Webull Corporation ("Webull"),a leading global digital investment platform,

Gupshup Accelerates AI Adoption For Businesses with Pre-Built, Industry-Trained, Multimodal AI Agents

Feb 14, 2025

JAKARTA,Indonesia,Feb. 13,2025-- Gupshup,the world\'s leading Conversational AI platform today announced the launch of its AI Agent Library,a groundbreaking suite of 15 pre-built and customizable AI

1 ... 80 81 82 83 84 85 86 ... 353